XORTX Therapeutics Inc (XRTX)
2.59
-0.31
(-10.75%)
USD |
NASDAQ |
Apr 25, 16:00
2.65
+0.06
(+2.32%)
After-Hours: 20:00
XORTX Therapeutics Cash from Investing (TTM): -0.0519M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -0.0519M |
June 30, 2023 | -0.0493M |
March 31, 2023 | -0.0613M |
December 31, 2022 | -0.0442M |
September 30, 2022 | -0.0422M |
June 30, 2022 | -0.047M |
March 31, 2022 | -0.0337M |
December 31, 2021 | -0.0312M |
September 30, 2021 | -0.0205M |
June 30, 2021 | -0.0147M |
March 31, 2021 | -0.0091M |
December 31, 2020 | -0.0113M |
September 30, 2020 | -0.0088M |
June 30, 2020 | -0.008M |
March 31, 2020 | -0.0077M |
December 31, 2019 | -0.0054M |
September 30, 2019 | -0.0021M |
June 30, 2019 | -0.0082M |
March 31, 2019 | -0.0037M |
Date | Value |
---|---|
December 31, 2018 | -0.1137M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
November 30, 2017 | |
September 30, 2017 | |
August 31, 2017 | -0.0041M |
May 31, 2017 | 0.0009M |
March 31, 2017 | 0.0009M |
February 28, 2017 | 0.0012M |
November 30, 2016 | 0.0055M |
August 31, 2016 | -0.0342M |
May 31, 2016 | -0.0379M |
February 29, 2016 | -0.0391M |
November 30, 2015 | -0.0389M |
August 31, 2015 | -0.0028M |
May 31, 2015 | -0.0037M |
February 28, 2015 | -0.0241M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.0613M
Minimum
Mar 2023
-0.0021M
Maximum
Sep 2019
-0.0254M
Average
-0.0176M
Median
Cash from Investing (TTM) Benchmarks
ImmunoPrecise Antibodies Ltd | -0.8794M |
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |